Now showing items 21-40 of 75

  • Fast acting SNARE-cleaving enzymes 

    Fletcher, Paul; Fletcher, Maryann; Martin, Brian (2015-10-06)
    The present invention relates to metalloprotease enzymes isolated from scorpion venom, their nucleic acid and amino acid sequences, and methods of use thereof in the treatment of various diseases, disorders and cosmetic ...
  • Fast acting SNARE-cleaving enzymes 

    Unknown author (2015-10-06)
    The present invention relates to metalloprotease enzymes isolated from scorpion venom, their nucleic acid and amino acid sequences, and methods of use thereof in the treatment of various diseases, disorders and cosmetic ...
  • Fixed dried red blood cells and method of use 

    Fischer, Thomas; Read, Marjorie; Bode, Arthur P.; Nichols, Timothy (2005-04-26)
    Fixed-dried red blood cells (RBCs), and processes for preparing the same are disclosed. The red blood cells, upon reconstitution with distilled water or appropriate buffer: bind oxygen with native affinities, have partial ...
  • Fixed-dried red blood cells 

    Fischer, Thomas; Read, Marjorie; Bode, Arthur P.; Nichols, Timothy (2008-04-15)
    Fixed-dried red blood cells (RBCs), and processes for preparing the same are disclosed. The red blood cells, upon reconstitution with distilled water or appropriate buffer: bind oxygen with native affinities, have partial ...
  • Frequency altered feedback for treating non-stuttering pathologies 

    Rastatter, Michael; Kalinowski, Joseph; Stuart, Andrew (2004-04-22)
    A device (10) and method for treating subjects having non-stuttering pathologies or disorders using frequency altered feedback including positioning a ear-supported device (10E) for receiving auditory signals associated ...
  • Frequency altered feedback for treating non-stuttering pathologies 

    Rastatter, Michael P.; Kalinowski, Joseph Stanley; Stuart, Andrew M. (2012-09-04)
    Methods and devices treat treating non-stuttering pathologies having impaired or decreased communication skills by administering a frequency altered auditory feedback signal to a subject having a non-stuttering pathology ...
  • Hox-gene expression as a biomarker for igf-1r therapeutics 

    Bertrand, Fred E.; Whelan, Jarrett Thomas (2008-09-25)
    This invention provides methods for treating or preventing the onset of a tumor in a subject, wherein the tumor is determined to overexpress a Hox gene, including administering to the subject a therapeutically or ...
  • In-ear hearing test probe devices and methods and systems using same 

    Givens, Gregg; Yao, Jianchu (2017-11-04)
    A medical hearing testing method includes: inserting an in-ear test probe that is coupled to a hearing test adapter into an ear of a patient at a patient site; receiving device identification data at a web portal operating ...
  • J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders 

    Van Dross, Rukiyah (2017-09-08)
    Provided is a method of preventing and/or treating a skin disorder and/or an oral disorder including administering to a subject in need thereof an effective amount of a compound of formula (I) or a prodrug or derivative ...
  • Low adenosine agent, composition, kit and method for treatment of airway disease 

    Nyce, Jonathan W.; Metzger, James (1999-11-30)
    An oligonucleotide which is antisense to a mRNA encoding a polypeptide involved in airway disease(s) contains up to three adenosines per every 21 nucleotide a method of treating airway disease in a subject in need of such ...
  • Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments 

    Nyce, Jonathan W. (2000-02-24)
    A composition comprises a nucleic acid comprising an oligo anti-sense to a target such as polypeptide(s) associated with an ailment afflicting lung airways, genes and mRNAs encoding them, genomic and mRNA flanking regions, ...
  • Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion 

    Nyce, Jonathan W. (2000-10-26)
    An in vivo method of selectively delivering a nucleic acid to a target gene or mRNA comprises the topical admistration, e.g. to the respiratory system, of a subject of a therapeutic amount of an oligonucleotide that is ...
  • Measles vaccine vectors and methods of use 

    Ross, Ted; Robinson, Harriet (2003-03-20)
    The present invention provides a novel vaccine expressing a fusion of the measles hemagglutinin (H) protein and the complement component, C3d, to enhance the titers of neutralizing antibody. Plasmids were generated that ...
  • Method and apparatus for treating renal disease with hemodialysis utilizing pulsatile pump 

    Bolin, Paul Jr. (2002-08-22)
    A method of removing toxins from blood from a patient in need of such toxin removal includes: providing a countercurrent dialysis filter (20) having a blood compartment and a dialysate compartment separated from the blood ...
  • Method for nerve growth induction 

    DeVanzo, John; Paul, Joseph W. (1993-03-16)
    A composition comprising nerve growth factor and 2-amino-1,1,3-tricyano-1-propene useful for the induction, stimulation, and maintenance of nerve growth, and methods of potentiating choline O-acetyltransferase and tyrosine ...
  • Method for nerve growth induction 

    Da Vanzo, John Paul; Paul, Joseph W. (1993-03-16)
    A composition comprising nerve growth factor and 2-amino-1,1,3-tricyano-1-propene useful for the induction, stimulation, and maintenance of nerve growth, and methods of potentiating choline O-acetyltransferase and tyrosine ...
  • Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone 

    Nyce, Jonathan W. (2000-07-11)
    A method and composition for reducing adenosine levels comprises administering a dehydroepiandrosterone, and optionally a ubiquinone.
  • Method for the microbial decontamination of blood platelets 

    Read, Marjorie S.; Bode, Arthur P.; Summarial, Louis J. (1999-04-06)
    A method for inactivating microbiological contaminants in a human blood platelet preparation is disclosed. The method comprises, first, providing blood platelets, particularly human blood platelets, suspected of being ...
  • Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds 

    Hayford, Anthony; Kaloko, Joseph (2006-07-13)
    A method of making a compound of Formula (I) comprises reacting a compound of Formula (II) with a compound such as R1OH or R1SH, to produce said compound of Formula (I). Compounds of Formula (I) are useful, among other ...
  • Method of detecting cancer using delta-catenin 

    Lu, Qun; Chen, Yan-Hua (2008-11-04)
    The present invention provides a method for detecting or screening for the presence of cancer in a subject. The method comprises obtaining, providing or collecting a tissue or fluid sample (such as a urine sample) from ...